BioSpace News Archive

Cumberland Pharmaceuticals Inc. announced that it will release fourth quarter and annual 2018 financial results after the market closes on Tuesday, February 26, 2019.

Sandoz Inc., a Novartis division, announced that the authorized generic of SUBOXONE® 1 Sublingual Film by Indivior Inc.

Invitae Corporation, a leading genetics company, announced financial and operating results for the fourth quarter and full year ended December 31, 2018.

Theravance Biopharma, Inc. announced that it will release financial results for the period ended December 31, 2018 and provide a business update after market close on Tuesday, February 26, 2019.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced that management will present at three upcoming investor conferences:

Lantheus Holdings, Inc. reported financial results for its fourth quarter and full year ended December 31, 2018.

Mirati Therapeutics, Inc., a clinical stage targeted oncology company, announced the appointment of Faheem Hasnain as Chairman of the Board, effective February 15, 2019.

Edwards Lifesciences Corporation announced the Edwards PASCAL transcatheter valve repair system has received CE Mark for the treatment of patients with mitral regurgitation.

Merck announced that the pivotal Phase 3 KEYNOTE-240 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, plus best supportive care, for the treatment of patients with advanced hepatocellular carcinoma who were previously treated with systemic therapy, did not meet its co-primary endpoints of overall survival and progression-free survival compared with placebo plus best supportive care.

Medical and Value Hearing Health Performance Drive Record Quarterly Revenue; Company Provides Guidance for 2019